<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">epidemiology</journal-id><journal-title-group><journal-title xml:lang="ru">Эпидемиология и Вакцинопрофилактика</journal-title><trans-title-group xml:lang="en"><trans-title>Epidemiology and Vaccinal Prevention</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2073-3046</issn><issn pub-type="epub">2619-0494</issn><publisher><publisher-name>«Numicom» LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.31631/2073-3046-2024-23-6-34-46</article-id><article-id custom-type="elpub" pub-id-type="custom">epidemiology-2117</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>Эпидемиология наиболее распространенных видов рака в Найнаве в 2017–2021 гг.</article-title><trans-title-group xml:lang="en"><trans-title>Epidemiology of the most Prevalent Cancers in Ninewa between 2017–2021</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Хатайер</surname><given-names>Ф. Х.</given-names></name><name name-style="western" xml:lang="en"><surname>Khathayer</surname><given-names>F. H.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Фирас Хамид Хатайер – кафедра биологии</p><p>г. Мосул</p><p>+9647718629224</p></bio><bio xml:lang="en"><p>Firas Hameed Khathayer – Department of Biology</p><p>+9647718629224</p></bio><email xlink:type="simple">firas.khathayer@uomosul.edu.iq</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Микаэль</surname><given-names>М. Х.</given-names></name><name name-style="western" xml:lang="en"><surname>Mikael</surname><given-names>M. H.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Мохаммед Хуссейн Микаэль – кафедра биологии</p><p>г. Мосула</p><p>+9647730073775</p></bio><bio xml:lang="en"><p>Mohammed Hussein Mikael – Department of Biology</p><p>+9647730073775</p></bio><email xlink:type="simple">mohsbio@uomosul.edu.iq</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кадхим</surname><given-names>С. З.</given-names></name><name name-style="western" xml:lang="en"><surname>Kadhim</surname><given-names>S. Z.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Сабах Зьяра Кадхим – отделение неотложной помощи</p><p>г. Стиллуотер, Оклахома</p><p>+18037438357</p></bio><bio xml:lang="en"><p>Sabah Zyara Kadhim – Department of Emergency Locum Veterinarian, Veterinary Medical Teaching Hospital</p><p>Stillwater, Oklahoma+18037438357</p></bio><email xlink:type="simple">Drsabah2115@yahoo.com</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Университет Мосула</institution><country>Ирак</country></aff><aff xml:lang="en"><institution>University of Mosul</institution><country>Iraq</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Университет штата Оклахома</institution><country>Соединённые Штаты Америки</country></aff><aff xml:lang="en"><institution>State University, Stillwater</institution><country>United States</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>12</day><month>01</month><year>2025</year></pub-date><volume>23</volume><issue>6</issue><fpage>34</fpage><lpage>46</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Хатайер Ф.Х., Микаэль М.Х., Кадхим С.З., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Хатайер Ф.Х., Микаэль М.Х., Кадхим С.З.</copyright-holder><copyright-holder xml:lang="en">Khathayer F.H., Mikael M.H., Kadhim S.Z.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.epidemvac.ru/jour/article/view/2117">https://www.epidemvac.ru/jour/article/view/2117</self-uri><abstract><p>Актуальность. Во всем мире рак является одним из самых опасных для жизни людей заболеваний, которое развивается независимо от пола, этнической принадлежности или национальности.Цель. Представить эпидемиологическую характеристику случаев злокачественных заболеваний в мухафазе Найнава1 (включая проценты, показатели заболеваемости, смертности и др.), зарегистрированных в 2017–2021 гг.Материалы и методы. В исследовании использовался ретроспективный аналитический эпидемиологический метод. Для сбора данных о различных типах рака, распространенных в Найнаве в 2017–2021 гг., использовали информационную базу Иракского реестра рака. Мы сосредоточились на 10 самых распространенных злокачественных заболеваний среди населения Найнавы.Результаты. Наше исследование показало, что количество новых случаев рака и смертность ежегодно увеличивались в рассматриваемый период. Среди женщин наблюдалась более высокая заболеваемость раком, чем среди мужчин. Наиболее распространенными видами рака в Найнаве были рак груди у женщин и рак легких у мужчин. В структуре злокачественных заболевания у детей лейкемия занимала первое место. Кроме того, это исследование показало, что рак легких имел самый высокий уровень смертности в Найнаве, за ним следует рак груди.Заключение. Наше исследование позволяет оценить ситуацию с онкологической заболеваемостью в мухафазе Найнава, и его результаты будут полезны врачам, преподавателям медицинских образовательных организаций и специалистам в области медицины.</p></abstract><trans-abstract xml:lang="en"><p>Purpose. Cancer is characterized by abnormal cell growth resulting from uncontrolled cell division. These cells spread and form metastatic lesions in normal tissues, leading to loss of tissue and organ function. Cancer is one of the most life-threatening diseases worldwide that develops in humans. regardless of sex, ethnicity, or nationality.Material and methods. Here, we conducted a retrospective study to collect data on the various types of cancers prevalent in Ninewa, Iraq, between 2017–2021, using hospital records pooled in the Iraq Cancer Registry. We focused on the top 10 most notable cancers prevalent in humans.Results. Our study revealed that number of novel cancer cases and mortality rates have been increasing annually between 2017– 2021. Females had higher rates of cancer occurrence than males. The most prevalent cancers in Ninewa were breast cancer in women and lung cancer in men. Leukemia was the most common pediatric cancer. Furthermore, this study reported that lung cancer had the highest mortality rate in Ninewa, followed by breast cancer.Conclusion Our study provides a statistical overview on cancer cases in the Ninewa governorate, and will be useful to clinicians, faculty members and other professionals in the medical field.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>эпидемиология</kwd><kwd>рак</kwd><kwd>заболеваемость</kwd><kwd>Найнава</kwd><kwd>смертность Конфликт интересов не заявлен</kwd></kwd-group><kwd-group xml:lang="en"><kwd>epidemiology</kwd><kwd>cancer</kwd><kwd>incidence</kwd><kwd>Ninewa</kwd><kwd>mortality</kwd><kwd>childhood cancer</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Мы хотели бы выразить нашу глубочайшую благодарность Министерству здравоохранения и охраны окружающей среды Республики Ирак, Иракскому совету по борьбе с раком, также каждому сотруднику каждого управления здравоохранения за их помощь в сборе данных. Мы благодарны Офису ВОЗ в Ираке за их техническую поддержку.</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Akinde OR, Phillips A A, Oguntunde, OA,and Afolayan OM (2015). Cancer mortality pattern in lagos university teaching hospital, lagos, Nigeria. Journal of cancer epidemiology, 2015, 842032. https://doi.org/10.1155/2015/842032</mixed-citation><mixed-citation xml:lang="en">Akinde OR, Phillips A A, Oguntunde, OA,and Afolayan OM (2015). Cancer mortality pattern in lagos university teaching hospital, lagos, Nigeria. Journal of cancer epidemiology, 2015, 842032. https://doi.org/10.1155/2015/842032</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Akinyemiju, T (2018). Epigenetic Biomarkers in Cancer Epidemiology, Editor(s): Sabita Saldanha, In Translational Epigenetics, Epigenetic Mechanisms in Cancer, Academic Press, Volume 3, Pages 223-241,</mixed-citation><mixed-citation xml:lang="en">Akinyemiju, T (2018). Epigenetic Biomarkers in Cancer Epidemiology, Editor(s): Sabita Saldanha, In Translational Epigenetics, Epigenetic Mechanisms in Cancer, Academic Press, Volume 3, Pages 223-241,</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Ala’din A. 2nd edition. Baghdad: Ministry of Health; 2004. Dec, MD, FRCP, FFPH. Health in Iraq, the Current situation, our vision for the future and areas of work.</mixed-citation><mixed-citation xml:lang="en">Ala’din A. 2nd edition. Baghdad: Ministry of Health; 2004. Dec, MD, FRCP, FFPH. Health in Iraq, the Current situation, our vision for the future and areas of work.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Al-Hashimi MM, Wang X.(2013). Comparing the cancer in Ninewa during three periods (1980-1990, 1991-2000, 2001-2010) using Poisson regression. J Res Med Sci. 18(12):1026-39. PMID: 24523792; PMCID: PMC3908522.</mixed-citation><mixed-citation xml:lang="en">Al-Hashimi MM, Wang X.(2013). Comparing the cancer in Ninewa during three periods (1980-1990, 1991-2000, 2001-2010) using Poisson regression. J Res Med Sci. 18(12):1026-39. PMID: 24523792; PMCID: PMC3908522.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Alkhayatt, TN , Ali, ZA and Younis AH, (2021). The prevalence and pattern of leukemia among children in Mosul, Iraq. Teikyo medical journal 44, (06), 4653-4657.</mixed-citation><mixed-citation xml:lang="en">Alkhayatt, TN , Ali, ZA and Younis AH, (2021). The prevalence and pattern of leukemia among children in Mosul, Iraq. Teikyo medical journal 44, (06), 4653-4657.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Ervik M, Lam F, Ferlay J, et al.(2018). Cancer Today. Lyon, France: International Agency for Research on Cancer; 2016</mixed-citation><mixed-citation xml:lang="en">Ervik M, Lam F, Ferlay J, et al.(2018). Cancer Today. Lyon, France: International Agency for Research on Cancer; 2016</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359–86. doi: 10.1002/ijc.29210</mixed-citation><mixed-citation xml:lang="en">Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359–86. doi: 10.1002/ijc.29210</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Hussain AM, Lafta RK.(2021). Cancer Trends in Iraq 2000-2016. Oman Med J. 36(1):e219. doi: 10.5001/omj.2021.18. PMID: 33552559; PMCID: PMC7847549.</mixed-citation><mixed-citation xml:lang="en">Hussain AM, Lafta RK.(2021). Cancer Trends in Iraq 2000-2016. Oman Med J. 36(1):e219. doi: 10.5001/omj.2021.18. PMID: 33552559; PMCID: PMC7847549.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">International Organization for Migration (2019). Rural areas in Ninewa, International Zone, Baghdad/Iraq</mixed-citation><mixed-citation xml:lang="en">International Organization for Migration (2019). Rural areas in Ninewa, International Zone, Baghdad/Iraq</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">M-Amen K, Abdullah OS, Amin AMS, et al.(2022). Cancer Incidence in the Kurdistan Region of Iraq: Results of a Seven-Year Cancer Registration in Erbil and Duhok Governorates. Asian Pac J Cancer Prev. 2022;23(2):601-615. Published 2022 Feb 1. doi:10.31557/APJCP.2022.23.2.601</mixed-citation><mixed-citation xml:lang="en">M-Amen K, Abdullah OS, Amin AMS, et al.(2022). Cancer Incidence in the Kurdistan Region of Iraq: Results of a Seven-Year Cancer Registration in Erbil and Duhok Governorates. Asian Pac J Cancer Prev. 2022;23(2):601-615. Published 2022 Feb 1. doi:10.31557/APJCP.2022.23.2.601</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Mattiuzzi C, Lippi G.(2019). Current Cancer Epidemiology. J Epidemiol Glob Health. 9(4):217-222. doi: 10.2991/jegh.k.191008.001. PMID: 31854162; PMCID: PMC7310786.</mixed-citation><mixed-citation xml:lang="en">Mattiuzzi C, Lippi G.(2019). Current Cancer Epidemiology. J Epidemiol Glob Health. 9(4):217-222. doi: 10.2991/jegh.k.191008.001. PMID: 31854162; PMCID: PMC7310786.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Oliveria SA, Christos PJ, Berwick M.(1997). The role of epidemiology in cancer prevention. Proc Soc Exp Biol Med. 216(2):142-50. doi: 10.3181/00379727-216-44164. PMID: 9349683.</mixed-citation><mixed-citation xml:lang="en">Oliveria SA, Christos PJ, Berwick M.(1997). The role of epidemiology in cancer prevention. Proc Soc Exp Biol Med. 216(2):142-50. doi: 10.3181/00379727-216-44164. PMID: 9349683.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F.(2020). Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4. PMID: 33538338.</mixed-citation><mixed-citation xml:lang="en">Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F.(2020). Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4. PMID: 33538338.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">WHO IARC.(2018). Estimated Cancer Incidence, Mortality and prevalence worldwide in 2012.fact sheet. Population fact sheet. 2018</mixed-citation><mixed-citation xml:lang="en">WHO IARC.(2018). Estimated Cancer Incidence, Mortality and prevalence worldwide in 2012.fact sheet. Population fact sheet. 2018</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Abulkhair O, Saadeddin A, Makram O, Gasmelseed A, Pasha T, Shehata H, Fakhoury HM.(2016). Vitamin D levels and breast cancer characteristics: Findings in patients from Saudi Arabia. J Steroid Biochem Mol Biol. 164:106-109. doi: 10.1016/j.jsbmb.2015.11.003. Epub 2015 Nov 7. PMID: 26554935.</mixed-citation><mixed-citation xml:lang="en">Abulkhair O, Saadeddin A, Makram O, Gasmelseed A, Pasha T, Shehata H, Fakhoury HM.(2016). Vitamin D levels and breast cancer characteristics: Findings in patients from Saudi Arabia. J Steroid Biochem Mol Biol. 164:106-109. doi: 10.1016/j.jsbmb.2015.11.003. Epub 2015 Nov 7. PMID: 26554935.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Al Balawi IA, Mir R, Abu-Duhier FM.(2018). Potential impact of vascular endothelial growth factor gene variation (−2578C&gt; A) on breast cancer susceptibility in Saudi Arabia: a case-control study. Asian Pac J Cancer Prev. 19:1135–1143.</mixed-citation><mixed-citation xml:lang="en">Al Balawi IA, Mir R, Abu-Duhier FM.(2018). Potential impact of vascular endothelial growth factor gene variation (−2578C&gt; A) on breast cancer susceptibility in Saudi Arabia: a case-control study. Asian Pac J Cancer Prev. 19:1135–1143.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Alhuquail AJ, Alzahrani A, Almubarak H, et al. (2018).High prevalence of deliterous BRCA 1 and BRCA 2 germline mutations in arab breast and ovarian cancer patients. Breast Cancer Res Treat. 2018</mixed-citation><mixed-citation xml:lang="en">Alhuquail AJ, Alzahrani A, Almubarak H, et al. (2018).High prevalence of deliterous BRCA 1 and BRCA 2 germline mutations in arab breast and ovarian cancer patients. Breast Cancer Res Treat. 2018</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Alqahtani WS, Almufareh NA, Domiaty DM, et al.(2020). Epidemiology of cancer in Saudi Arabia thru 2010-2019: a systematic review with constrained meta-analysis. AIMS Public Health. 7(3):679-696. Published 2020 Sep 11. doi:10.3934/publichealth.2020053</mixed-citation><mixed-citation xml:lang="en">Alqahtani WS, Almufareh NA, Domiaty DM, et al.(2020). Epidemiology of cancer in Saudi Arabia thru 2010-2019: a systematic review with constrained meta-analysis. AIMS Public Health. 7(3):679-696. Published 2020 Sep 11. doi:10.3934/publichealth.2020053</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Alwan N, Kerr D.(2018). Cancer control in war-torn Iraq. Lancet Oncol. 19:291–2. doi: 10.1016/S1470-2045(18)30135-9.</mixed-citation><mixed-citation xml:lang="en">Alwan N, Kerr D.(2018). Cancer control in war-torn Iraq. Lancet Oncol. 19:291–2. doi: 10.1016/S1470-2045(18)30135-9.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">American cancer society (2020). Childhood Leukemia Causes, Risk Factors, and Prevention. Cancer.org. USA . https://www.cancer.org/cancer/types/leukemia-in-children/about/new-research. html</mixed-citation><mixed-citation xml:lang="en">American cancer society (2020). Childhood Leukemia Causes, Risk Factors, and Prevention. Cancer.org. USA . https://www.cancer.org/cancer/types/leukemia-in-children/about/new-research. html</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Cancer research UK (2023). Risks and causes of lung cancer. England and Wales</mixed-citation><mixed-citation xml:lang="en">Cancer research UK (2023). Risks and causes of lung cancer. England and Wales</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Farmer P, Frenk J, Knaul FM, Shulman LN, Alleyne G, Armstrong L, et al.(2010). Expansion of cancer care and control in countries of low and middle income: A call to action. Lancet. 376:1186–93. doi: 10.1016/S0140-6736(10)61152-X.</mixed-citation><mixed-citation xml:lang="en">Farmer P, Frenk J, Knaul FM, Shulman LN, Alleyne G, Armstrong L, et al.(2010). Expansion of cancer care and control in countries of low and middle income: A call to action. Lancet. 376:1186–93. doi: 10.1016/S0140-6736(10)61152-X.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Fathi RA, Matti LY, Al-Salih HS, (2013).Godbold D. Environmental pollution by depleted uranium in Iraq with special reference to Mosul and possible effects on cancer and birth defect rates. Med Confl Surviv 29(1):7-25 . 10.1080/13623699.2013.765173</mixed-citation><mixed-citation xml:lang="en">Fathi RA, Matti LY, Al-Salih HS, (2013).Godbold D. Environmental pollution by depleted uranium in Iraq with special reference to Mosul and possible effects on cancer and birth defect rates. Med Confl Surviv 29(1):7-25 . 10.1080/13623699.2013.765173</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Fuliful FK, Ali RHA. and Ali,KHA (2021). A Statistical Analysis on the Incidence Rate of Lung Cancer in Karbala-Iraq during 2012-19, International Journal of Medical Research &amp; Health Sciences, 10(3): 40-52</mixed-citation><mixed-citation xml:lang="en">Fuliful FK, Ali RHA. and Ali,KHA (2021). A Statistical Analysis on the Incidence Rate of Lung Cancer in Karbala-Iraq during 2012-19, International Journal of Medical Research &amp; Health Sciences, 10(3): 40-52</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Habib SO, Hameed AL, Ajeel AN, Al-Hawaz MH, Al-Faddagh ZA, Nasr NG, et al. (2016).Epidemiology of breast cancer among females in Basrah. Asian Pac J Cancer Prev. 17:191–5. doi: 10.7314/apjcp.2016.17.s3.191.</mixed-citation><mixed-citation xml:lang="en">Habib SO, Hameed AL, Ajeel AN, Al-Hawaz MH, Al-Faddagh ZA, Nasr NG, et al. (2016).Epidemiology of breast cancer among females in Basrah. Asian Pac J Cancer Prev. 17:191–5. doi: 10.7314/apjcp.2016.17.s3.191.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Hamadeh RR, Borgan SM, Sibai AM.(2017). Cancer research in the Arab world: A review of publications from seven countries between 2000–2013. Sultan Qaboos Univ Med J. 17:e147–54. doi: 10.18295/squmj.2016.17.02.003</mixed-citation><mixed-citation xml:lang="en">Hamadeh RR, Borgan SM, Sibai AM.(2017). Cancer research in the Arab world: A review of publications from seven countries between 2000–2013. Sultan Qaboos Univ Med J. 17:e147–54. doi: 10.18295/squmj.2016.17.02.003</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Hussain AM, Lafta RK.(2021). Cancer Trends in Iraq 2000-2016. Oman Med J. 36(1):e219. Published 2021 Jan 31. doi:10.5001/omj.2021.18</mixed-citation><mixed-citation xml:lang="en">Hussain AM, Lafta RK.(2021). Cancer Trends in Iraq 2000-2016. Oman Med J. 36(1):e219. Published 2021 Jan 31. doi:10.5001/omj.2021.18</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Ibrahim BA, Al-Humaish S and Al-Obaide MAI (2018). Tobacco Smoking, Lung Cancer, and Therapy in Iraq: Current Perspective. Front. Public Health 6:311. doi: 10.3389/fpubh. 2018 .00311</mixed-citation><mixed-citation xml:lang="en">Ibrahim BA, Al-Humaish S and Al-Obaide MAI (2018). Tobacco Smoking, Lung Cancer, and Therapy in Iraq: Current Perspective. Front. Public Health 6:311. doi: 10.3389/fpubh. 2018 .00311</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Ifediora CO.(2019). Re-thinking breast and cervical cancer preventive campaigns in developing countries: the case for interventions at high schools. BMC Public Health. 3;19(1):503. doi: 10.1186/s12889-019-6890-2. PMID: 31053073; PMCID: PMC6500011.</mixed-citation><mixed-citation xml:lang="en">Ifediora CO.(2019). Re-thinking breast and cervical cancer preventive campaigns in developing countries: the case for interventions at high schools. BMC Public Health. 3;19(1):503. doi: 10.1186/s12889-019-6890-2. PMID: 31053073; PMCID: PMC6500011.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Kim, H. I., Lim, H., &amp; Moon, A. (2018). Sex Differences in Cancer: Epidemiology, Genetics and Therapy. Biomolecules &amp; therapeutics, 26(4), 335–342.</mixed-citation><mixed-citation xml:lang="en">Kim, H. I., Lim, H., &amp; Moon, A. (2018). Sex Differences in Cancer: Epidemiology, Genetics and Therapy. Biomolecules &amp; therapeutics, 26(4), 335–342.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Mir R, Javid J, Al Balawi A, et al.(2018). A germline mutation in BRCA1 3’UTR variant predicts susceptibility to breast cancer in a Saudi Arabian population. Asian Pac J Cancer Prev. 19:859–866.</mixed-citation><mixed-citation xml:lang="en">Mir R, Javid J, Al Balawi A, et al.(2018). A germline mutation in BRCA1 3’UTR variant predicts susceptibility to breast cancer in a Saudi Arabian population. Asian Pac J Cancer Prev. 19:859–866.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Mojsak D, Dębczyński M, Kuklińska B, et al.(2023). Impact of COVID-19 in Patients with Lung Cancer: A Descriptive Analysis. Int J Environ Res Public Health. 20(2):1583. Published 2023 Jan 15. doi:10.3390/ijerph20021583</mixed-citation><mixed-citation xml:lang="en">Mojsak D, Dębczyński M, Kuklińska B, et al.(2023). Impact of COVID-19 in Patients with Lung Cancer: A Descriptive Analysis. Int J Environ Res Public Health. 20(2):1583. Published 2023 Jan 15. doi:10.3390/ijerph20021583</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Noronha V, Pinninti R, Patil VM, Joshi A, Prabhash K.(2016). Lung cancer in the Indian subcontinent. South Asian J Cancer. 5(3):95-103. doi:10.4103/2278-330X.187571</mixed-citation><mixed-citation xml:lang="en">Noronha V, Pinninti R, Patil VM, Joshi A, Prabhash K.(2016). Lung cancer in the Indian subcontinent. South Asian J Cancer. 5(3):95-103. doi:10.4103/2278-330X.187571</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Prager GW, Braga S, Bystricky B, Qvortrup C, Criscitiello C, Esin E, et al.(2018). Global cancer control: Responding to the growing burden, rising costs and inequalities in access. ESMO Open. 3:e000285. doi: 10.1136/esmoopen-2017-000285.</mixed-citation><mixed-citation xml:lang="en">Prager GW, Braga S, Bystricky B, Qvortrup C, Criscitiello C, Esin E, et al.(2018). Global cancer control: Responding to the growing burden, rising costs and inequalities in access. ESMO Open. 3:e000285. doi: 10.1136/esmoopen-2017-000285.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Pramesh, C.S., Badwe, R.A., Bhoo-Pathy, N. et al.( 2022).Priorities for cancer research in low- and middle-income countries: a global perspective. Nat Med 28, 649–657 .Apr;28(4):649-657.</mixed-citation><mixed-citation xml:lang="en">Pramesh, C.S., Badwe, R.A., Bhoo-Pathy, N. et al.( 2022).Priorities for cancer research in low- and middle-income countries: a global perspective. Nat Med 28, 649–657 .Apr;28(4):649-657.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">doi: 10.1038/s41591-022-01738-x.</mixed-citation><mixed-citation xml:lang="en">doi: 10.1038/s41591-022-01738-x.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Rahman S, Zayed H. (2018).Breast cancer in the GCC countries: A focus on BRCA1/2 and non-BRCA1/2 genes. Gene. 20;668:73-76. doi: 10.1016/j.gene.2018.05.045. Epub 2018 May 17. PMID: 29777908.</mixed-citation><mixed-citation xml:lang="en">Rahman S, Zayed H. (2018).Breast cancer in the GCC countries: A focus on BRCA1/2 and non-BRCA1/2 genes. Gene. 20;668:73-76. doi: 10.1016/j.gene.2018.05.045. Epub 2018 May 17. PMID: 29777908.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Reyes R., López-Castro R., Auclin E., García T., Chourio M.J., Rodriguez A., López L., Laguna J.C., Lucena C., Molins L., et al(2021).. MA03.08 Impact of COVID-19 Pandemic in the Diagnosis and Prognosis of Lung Cancer. J. Thorac. Oncol. 2021;16:S141.</mixed-citation><mixed-citation xml:lang="en">Reyes R., López-Castro R., Auclin E., García T., Chourio M.J., Rodriguez A., López L., Laguna J.C., Lucena C., Molins L., et al(2021).. MA03.08 Impact of COVID-19 Pandemic in the Diagnosis and Prognosis of Lung Cancer. J. Thorac. Oncol. 2021;16:S141.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Saeed, S. M.,(2009). Epstein-Barr virus in Hodgkin’s lymphoma-immunohistochemical case series study. Annals of the College of Medicine, Mosul, 2009. 35(2): p. 93-103.</mixed-citation><mixed-citation xml:lang="en">Saeed, S. M.,(2009). Epstein-Barr virus in Hodgkin’s lymphoma-immunohistochemical case series study. Annals of the College of Medicine, Mosul, 2009. 35(2): p. 93-103.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Safiri, S., Noori, M., Nejadghaderi, S. et al. Burden of female breast cancer in the Middle East and North Africa region, 1990–2019. Arch Public Health 80, 168 (2022).</mixed-citation><mixed-citation xml:lang="en">Safiri, S., Noori, M., Nejadghaderi, S. et al. Burden of female breast cancer in the Middle East and North Africa region, 1990–2019. Arch Public Health 80, 168 (2022).</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62:10–29. doi: 10.3322/caac.20138.</mixed-citation><mixed-citation xml:lang="en">Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62:10–29. doi: 10.3322/caac.20138.</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Wang Y, Freemantle N, Nazareth I, Hunt K. Gender differences in survival and the use of primary care prior to diagnosis of three cancers: An analysis of routinely collected UK general practice data. PLoS One. 2014;9:e101562. doi: 10.1371/journal.pone.0101562.</mixed-citation><mixed-citation xml:lang="en">Wang Y, Freemantle N, Nazareth I, Hunt K. Gender differences in survival and the use of primary care prior to diagnosis of three cancers: An analysis of routinely collected UK general practice data. PLoS One. 2014;9:e101562. doi: 10.1371/journal.pone.0101562.</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Yue W, Wang JP, Li Y, et al. Effects of estrogen on breast cancer development: Role of estrogen receptor independent mechanisms. Int J Cancer. 2010;127(8):1748-1757. doi:10.1002/ijc.25207</mixed-citation><mixed-citation xml:lang="en">Yue W, Wang JP, Li Y, et al. Effects of estrogen on breast cancer development: Role of estrogen receptor independent mechanisms. Int J Cancer. 2010;127(8):1748-1757. doi:10.1002/ijc.25207</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
